The page is the record's research on the issuer — no analyst, no rating, no view.

# Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Arcturus Therapeutics Holdings Inc., listed on NASDAQ under ticker ARCT, with ISIN US03969T1097. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Delaware. The segment is not on the record. The listing status is listed, not halted.

## The disclosure read

The record holds 41 filings across 23 filing days in the twelve months to 2026-11-08, from 2025-11-08. The median gap between filing days is 14.0 days. The latest filing is a results filing dated 2026-11-05, 3 days before the record date. On NASDAQ the median filings count is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days across 4359 issuers. On the sector 2834 Pharmaceutical Preparations the median filings count is 63.0, the median cadence gap is 6.0 days and the median latency is 4.0 days across 526 issuers. The issuer's 41 filings are below the NASDAQ median and below the sector median.

## Auditor

The auditor of record is Deloitte & Touche LLP, located in San Diego, California. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable for any client category because the chapter's orderability section carries no client categories. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations pages read.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer is sealed for the years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001768224.json (identity.jurisdiction)
- https://mcp.us-cm-kg.ai/events/NASDAQ/ARCT (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1768224/000119312526088391/arct-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/ARCT (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ARCT · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
